DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...

PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...

With the S&P 500 down 3.1% and the Nasdaq Composite sliding 3.5% in the past week, Bernstein analysts suggest that this ...

Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest ...

Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

The FDA cited issues with DexCom's response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7, 2024, ...

The investor has been working behind the scenes at the tech-services firm and isn't currently planning to nominate directors. The regulator said Robinhood had violated "numerous" rules, including ...